Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

A clinical trial evaluates the efficacy of montelukast in migraine prophylaxis

July 12, 2004

Lyrica approved in E.U.

July 12, 2004

Vanilloid receptor antagonists for the treatment of pain

July 12, 2004

Phosphodiesterase 4 inhibitors claimed by Memory Pharmaceuticals

July 12, 2004

Phase I study for neuroprotectant KTX-0101

July 12, 2004

Hemantane has protective effect in MPP+ model of Parkinson's

July 12, 2004

Update on the clinical benefits of rasagiline in PD

July 12, 2004

Cellular process in cognition enhancement improved by 5-HT6 receptor antagonists

July 9, 2004

Anxiolytic effects of NK1 and CRF1 receptor antagonists in marmosets

July 9, 2004

Antidepressant and anxiolytic properties of agomelatine

July 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...